A pharmaceutical company that specializes in the production of medication kits used for the treatment of diabetes, ...

Starting treatment in the first month after diagnosis increases the likelihood of blood pressure control with lasting ...

Recently approved medications for resistant hypertension, uncomplicated UTIs and menopausal hot flashes show potential as ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first quarter of 2025.

Improved hypertension control can save millions of lives, but mass hypertension screening, a commonly used approach, is a barrier to progress. Although politically appealing, mass screening diverts ...

Aortic aneurysms — dangerous bulges in the body’s main artery, the aorta — are becoming increasingly common as more people ...

Treatment of hypertension (HTN ... Thiazides are widely used as first-line therapy for hypertension. In patients with HF, the more potent loop diuretics are preferred. Furthermore, in HF patients ...

The research highlights sex-based differences at each step of the "health pathway", which includes being exposed to a risk ...

Urolithiasis is a highly prevalent and multifactorial disease, representing the most common urological condition globally.

Researchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to ...

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine ... uncontrolled hypertension, peripheral arterial disease ...